[{"id":"577d5037-eb6e-4785-b20b-69876702f3ed","acronym":"","url":"https://clinicaltrials.gov/study/NCT04671875","created_at":"2021-03-09T09:00:11.648Z","updated_at":"2024-07-02T16:35:14.865Z","phase":"Phase 1","brief_title":"A Clinical Study of MIL93 in Solid Tumors.","source_id_and_acronym":"NCT04671875","lead_sponsor":"Beijing Mabworks Biotech Co., Ltd.","biomarkers":" CLDN18","pipe":" | ","alterations":" CLDN18.2 positive","tags":["CLDN18"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CLDN18.2 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MIL93"],"overall_status":"Recruiting","enrollment":" Enrollment 228","initiation":"Initiation: 04/21/2021","start_date":" 04/21/2021","primary_txt":" Primary completion: 08/01/2025","primary_completion_date":" 08/01/2025","study_txt":" Completion: 08/01/2025","study_completion_date":" 08/01/2025","last_update_posted":"2024-03-13"}]